精优药业(00858)发布中期业绩 股东应占亏损4.6亿港元 同比盈转亏
EXTRAWELL PHAREXTRAWELL PHAR(HK:00858) Zhi Tong Cai Jing·2025-11-28 15:24

Core Viewpoint - The company reported a significant decline in revenue and a shift from profit to loss in its interim results for the six months ending September 30, 2025 [1] Financial Performance - Revenue for the period was HKD 28.08 million, representing a year-on-year decrease of 9.04% [1] - The company recorded a loss attributable to shareholders of HKD 460 million, a shift from profit to loss compared to the previous year [1] - Earnings per share were reported at a loss of HKD 0.1909 [1]